LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 11

Search options

  1. Article ; Online: An Uncommon Presentation of Secondary Syphilis.

    Nicolau, Rafaela / Oliveira, Daniela / Pacheco, João / Madureira, Pedro

    The Journal of rheumatology

    2024  

    Abstract: Syphilis is a chronic venereal disease caused ... ...

    Abstract Syphilis is a chronic venereal disease caused by
    Language English
    Publishing date 2024-03-15
    Publishing country Canada
    Document type Journal Article
    ZDB-ID 194928-7
    ISSN 1499-2752 ; 0315-162X
    ISSN (online) 1499-2752
    ISSN 0315-162X
    DOI 10.3899/jrheum.2024-0119
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: McCune-Albright syndrome: Beyond classical craniofacial deformities.

    Nicolau, Rafaela / Beirão, Tiago / Guimarães, Francisca / Ganhão, Sara / Aguiar, Francisca / Rodrigues, Mariana / Brito, Iva

    Joint bone spine

    2024  Volume 91, Issue 4, Page(s) 105717

    Language English
    Publishing date 2024-03-05
    Publishing country France
    Document type Journal Article
    ZDB-ID 2020487-5
    ISSN 1778-7254 ; 1297-319X
    ISSN (online) 1778-7254
    ISSN 1297-319X
    DOI 10.1016/j.jbspin.2024.105717
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Pulmonary sarcoidosis and immune-mediated necrotizing myopathy: an uncommon coincidence.

    Martins, Ana / Pimenta, Sofia / Martins, Frederico Rajão / Samões, Beatriz / Nicolau, Rafaela / Mariz, Eva / Costa, Lúcia

    ARP rheumatology

    2024  Volume 2, Issue 4, Page(s) 341–344

    Abstract: Introduction: Immune-mediated necrotizing myopathy (IMNM) is characterized by acute or subacute, severe proximal muscle weakness and myofiber necrosis with minimal inflammatory cell infiltrate observed on muscle biopsy. On the other hand, sarcoidosis is ...

    Title translation Pulmonary sarcoidosis and immune-mediated necrotizing myopathy: an uncommon coincidence.
    Abstract Introduction: Immune-mediated necrotizing myopathy (IMNM) is characterized by acute or subacute, severe proximal muscle weakness and myofiber necrosis with minimal inflammatory cell infiltrate observed on muscle biopsy. On the other hand, sarcoidosis is characterised by the presence of non-caseating granulomas that can develop in several organs.
    Case report: We present the unique case of a 49-year-old woman, with no previous medical history, who had a rare concomitant occurrence of IMNM and pulmonary sarcoidosis. This condition was successfully treated with a combination of corticosteroids and rituximab along with rehabilitation program.
    Discussion: This association has been reported in only two previous case reports. This highlights the importance of further research on the connection between sarcoidosis and other forms of inflammatory myopathies.
    MeSH term(s) Female ; Humans ; Middle Aged ; Sarcoidosis, Pulmonary/complications ; Myositis/complications ; Autoimmune Diseases/pathology ; Sarcoidosis/pathology ; Muscle Weakness ; Soft Tissue Injuries
    Language English
    Publishing date 2024-01-04
    Publishing country Portugal
    Document type Case Reports ; Journal Article
    ISSN 2795-4552
    ISSN (online) 2795-4552
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Correction to: What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs?

    Martins, Ana / Oliveira, Daniela / Nicolau, Rafaela / Rocha, Teresa Martins / Bernardo, Alexandra / Costa, Lúcia / Pimenta, Sofia / Bernardes, Miguel

    Clinical rheumatology

    2024  Volume 43, Issue 3, Page(s) 1275

    Language English
    Publishing date 2024-01-30
    Publishing country Germany
    Document type Published Erratum
    ZDB-ID 604755-5
    ISSN 1434-9949 ; 0770-3198
    ISSN (online) 1434-9949
    ISSN 0770-3198
    DOI 10.1007/s10067-024-06875-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Systemic sclerosis and sarcoidosis: an exceptional coexistence.

    Nicolau, Rafaela / Pinheiro, Filipe Oliveira / Pacheco, João / Rocha, Teresa Martins / Morais, António / Costa, Lúcia

    ARP rheumatology

    2022  

    Title translation Systemic sclerosis and sarcoidosis: an exceptional coexistence.
    Language English
    Publishing date 2022-06-12
    Publishing country Portugal
    Document type Journal Article
    ISSN 2795-4552
    ISSN (online) 2795-4552
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Immune-mediated skin lesions related to biological disease-modifying antirheumatic drugs: a 22-year experience of a tertiary center.

    Martins, Ana / Oliveira, Daniela / Martins, Frederico Rajão / Nicolau, Rafaela / Pinheiro, Filipe Oliveira / Rato, Maria Seabra / Pimenta, Sofia / Costa, Lúcia / Bernardes, Miguel

    ARP rheumatology

    2023  

    Abstract: Introduction: Immune-mediated skin lesions (IMSL) can be very disabling leading to treatment discontinuation. Although these lesions have rarely been previously described, the true incidence is unknown.: Objective: To explore the cumulative incidence, ...

    Title translation Immune-mediated skin lesions related to biological disease-modifying antirheumatic drugs: a 22-year experience of a tertiary center.
    Abstract Introduction: Immune-mediated skin lesions (IMSL) can be very disabling leading to treatment discontinuation. Although these lesions have rarely been previously described, the true incidence is unknown.
    Objective: To explore the cumulative incidence, management and outcomes of IMSL related to bDMARD in a large cohort of patients with chronic inflammatory rheumatic diseases. To explore possible associations and risk factors for IMSL development.
    Methods: A retrospective single-center study of patients with rheumatoid arthritis (RA), spondylarthritis (SpA) and psoriatic arthritis (PsA) that had been treated with at least one bDMARD for at least 6 months was conducted. IMSL related to bDMARD characteristics and outcomes were collected.
    Results: A total of 989 patients with RA, SpA and PsA were included. Twenty-seven patients (2.7%) presented IMSL potentially related to bDMARD, being psoriasis the most common IMSL (n=12, 44.4%), followed by drug-induced lupus erythematosus (n=6), alopecia areata (n=3) and leukocytoclastic vasculitis (n=2). IMSL led to withdrawal of bDMARD in 18 of the 27 patients (66.7%). Patients with IMSL had younger age at diagnosis (p=0.038), longer disease duration (p=0.018), longer duration of bDMARD treatment (p=0.008), and higher number of previous bDMARDs (p < 0.001) than patients without IMSL. In the group of patients with IMSL there was a significantly higher percentage of patients treated with adalimumab (p < 0.001). In multivariate regression model, the number of previous bDMARDs (OR 2.13, 95%CI 1.47-3.10, p < 0.001) and treatment with adalimumab (OR 4.60, 95%CI 1.96-10.80 , p < 0.001) were statistically significant predictive factors for IMSL development.
    Conclusion: In our study, IMSL related to bDMARDs had an estimated cumulative incidence of 2.7%. Younger age at diagnosis, longer disease duration, longer duration of bDMARD treatment, higher number of previous bDMARDs and treatment with adalimumab were independently associated with an increased risk of IMSL development.
    Language English
    Publishing date 2023-07-19
    Publishing country Portugal
    Document type Journal Article
    ISSN 2795-4552
    ISSN (online) 2795-4552
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing.

    Nicolau, Rafaela / Beirão, Tiago / Guimarães, Francisca / Aguiar, Francisca / Ganhão, Sara / Rodrigues, Mariana / Grangeia, Ana / Brito, Iva

    Pediatric rheumatology online journal

    2023  Volume 21, Issue 1, Page(s) 48

    Abstract: Background: Primary Hypertrophic Osteoarthropathy (PHO), also known as Touraine-Solente-Gole Syndrome, is a rare, multisystemic autosomal recessive disorder caused by pathogenic variants in the 15-hydroxyprostaglandin dehydrogenase (HPGD) or Solute ... ...

    Abstract Background: Primary Hypertrophic Osteoarthropathy (PHO), also known as Touraine-Solente-Gole Syndrome, is a rare, multisystemic autosomal recessive disorder caused by pathogenic variants in the 15-hydroxyprostaglandin dehydrogenase (HPGD) or Solute Carrier Organic Anion Transporter Family Member 2A1 (SLCO2A1) genes. However, autosomal dominant transmission has also been described in some families with incomplete penetrance. PHO usually starts in childhood or adolescence, presenting with digital clubbing, osteoarthropathy, and pachydermia. We described a complete form of the syndrome in a male patient with a homozygous variant in the SLCO2A1 gene (c.1259G > T).
    Case presentation: A 20-year-old male was referred to our Pediatric Rheumatology Clinic with a five-year history of painful and swollen hands, knees, ankles and feet, prolonged morning stiffness and relief with non-steroidal antiinflammatory drugs. He also reported late onset facial acne and palmoplantar hyperhidrosis. Family history was irrelevant and parents were non-consanguineous. On clinical examination, he presented clubbing of the fingers and toes, moderate acne and marked facial skin thickening with prominent scalp folds. He had hand, knee, ankles and feet swelling. Laboratory investigations showed elevated inflammatory markers. Complete blood count, renal and hepatic function, bone biochemistry were normal, as well as immunological panel. Plain radiographs revealed soft tissue swelling, periosteal ossification and cortical thickening of the skull, phalanges, femur and toe acroosteolysis. Due to the absence of other clinical signs suggesting a secondary cause, we suspected PHO. A genetic study revealed a likely pathogenic variant, c.1259G > T(p.Cys420Phe), in homozygosity in the SLCO2A1 gene, thus confirming the diagnosis. The patient started oral naproxen with significant clinical improvement.
    Conclusions: PHO should be kept in the differential diagnosis of inflammatory arthritis affecting children, often misdiagnosed as Juvenile Idiopathic Arthritis (JIA). To the best of our knowledge, this is the second genetically confirmed case of PHO in a Portuguese patient (first variant c.644 C > T), both made at our department.
    MeSH term(s) Humans ; Male ; Young Adult ; Arthralgia ; Hand ; Musculoskeletal Diseases ; Organic Anion Transporters/genetics ; Osteoarthropathy, Primary Hypertrophic/diagnosis ; Osteoarthropathy, Primary Hypertrophic/genetics ; Pain
    Chemical Substances Organic Anion Transporters ; SLCO2A1 protein, human
    Language English
    Publishing date 2023-05-24
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 2279468-2
    ISSN 1546-0096 ; 1546-0096
    ISSN (online) 1546-0096
    ISSN 1546-0096
    DOI 10.1186/s12969-023-00831-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Correction to: Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing.

    Nicolau, Rafaela / Beirão, Tiago / Guimarães, Francisca / Aguiar, Francisca / Ganhão, Sara / Rodrigues, Mariana / Grangeia, Ana / Brito, Iva

    Pediatric rheumatology online journal

    2023  Volume 21, Issue 1, Page(s) 62

    Language English
    Publishing date 2023-06-26
    Publishing country England
    Document type Published Erratum
    ZDB-ID 2279468-2
    ISSN 1546-0096 ; 1546-0096
    ISSN (online) 1546-0096
    ISSN 1546-0096
    DOI 10.1186/s12969-023-00850-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs?

    Martins, Ana / Oliveira, Daniela / Nicolau, Rafaela / Rocha, Teresa Martins / Bernardo, Alexandra / Costa, Lúcia / Pimenta, Sofia / Bernardes, Miguel

    Clinical rheumatology

    2023  Volume 43, Issue 1, Page(s) 251–258

    Abstract: Introduction: Psoriatic arthritis (PsA) is a chronic, progressive inflammatory joint disease that is associated with higher prevalence of depression. There is limited literature about the impact of depression, particularly regarding the response to ... ...

    Abstract Introduction: Psoriatic arthritis (PsA) is a chronic, progressive inflammatory joint disease that is associated with higher prevalence of depression. There is limited literature about the impact of depression, particularly regarding the response to therapy.
    Methods: A retrospective cohort study with PsA patients that started their first biologic disease-modifying antirheumatic drugs (bDMARD) was conducted. In the majority of cases, a cutoff score of ≥ 8 in Hospital Anxiety and Depression Scale (HADS) was used to define cases of depression. In cases where patients did not complete the questionnaire, a previous diagnosis made by a psychiatrist was used to establish the presence of depression. Response to therapy 12 months after the start of bDMARD was evaluated and the switch rate to another bDMARD due to inefficacy was assessed at month 12.
    Results: A total of 129 patients (66 females, 51.2%; mean age of 47.7 ± 11.0 years and mean disease duration of 10.0 ± 7.7 years) with PsA were included. Thirty-two (24.8%) patients had depression. Patients with depression and peripheral involvement had a significantly lower ACR20/50/70 responses (p = 0.001, p = 0.002, and p = 0.001 respectively) after 12 months of therapy and a significantly worse EULAR response (p = 0.002). Furthermore, patients with depression and axial involvement had a significantly worse response based on ASDAS response criteria (p = 0.031). Switch due to ineffectiveness in the first 12 months was significantly higher in patients with depression (p = 0.002).
    Conclusion: Depression in PsA is a frequent yet often understudied comorbidity. The causal relationship between depression and PsA is difficult to decrypt and further research is needed. Recognition of depressive symptoms is crucial and a multidisciplinary approach should be provided to individuals with this comorbidity. Key Points • Depression in PsA is a frequent yet often understudied comorbidity. In our study, the prevalence of depression was 24.8%. • Depression in PsA seems to be associated to lower response to therapy and higher discontinuation rates of bDMARD. • Recognition of depressive symptoms is crucial and a multidisciplinary approach should be provided to individuals with this comorbidity.
    MeSH term(s) Female ; Humans ; Adult ; Middle Aged ; Arthritis, Psoriatic/complications ; Arthritis, Psoriatic/drug therapy ; Arthritis, Psoriatic/diagnosis ; Retrospective Studies ; Depression/complications ; Depression/epidemiology ; Biological Products/therapeutic use ; Antirheumatic Agents/therapeutic use
    Chemical Substances Biological Products ; Antirheumatic Agents
    Language English
    Publishing date 2023-11-14
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 604755-5
    ISSN 1434-9949 ; 0770-3198
    ISSN (online) 1434-9949
    ISSN 0770-3198
    DOI 10.1007/s10067-023-06806-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Anti-SSA Ro52 and anti-Ro60 autoantibodies: association with clinical phenotypes.

    Mazeda, Carolina / Oliveira, Natacha / Abreu, Catarina / Fraga, Vanessa / Maduro, Isabel / Saraiva, André / Inês, Luís / Ferreira, Carla / Correia, Ana Margarida / Nicolau, Rafaela / Farinha, Filipa / Villanueva, Ingrid / Jesus, Diogo / Abreu, Pedro / Neto, Agna / Silva Dinis, Joana / Barcelos, Anabela

    Clinical and experimental rheumatology

    2024  

    Abstract: Objectives: Anti-SSA autoantibodies can be differentiated according to their antigenic target proteins as anti-Ro60 (60 kDa) or anti-Ro52 (52 kDa). Anti-SSA(Ro60) antibodies are clearly associated with connective tissue diseases (CTD), but the clinical ... ...

    Abstract Objectives: Anti-SSA autoantibodies can be differentiated according to their antigenic target proteins as anti-Ro60 (60 kDa) or anti-Ro52 (52 kDa). Anti-SSA(Ro60) antibodies are clearly associated with connective tissue diseases (CTD), but the clinical significance of anti-SSA(Ro52) antibodies remains unclear. The aim of the present study was to analyse the disease phenotype of patients with anti-Ro52 and/or anti-Ro60 antibodies.
    Methods: A multicentre, cross-sectional study was carried out of positive anti-Ro52 and/or Ro60 antibodies patients followed at 10 Rheumatology centres from January 2018 until December 2021. Patients were categorised into 3 groups: group 1 (Ro52+/Ro60-); group 2 (Ro52-/Ro60+); group 3 (Ro52+/Ro60+). Antinuclear antibodies were evaluated by indirect immunofluorescence assay and further screened for anti-extractable nuclear antigen (ENA) antibodies. Demographicsand clinical data were compared between the 3 groups, by patients' medical chart review. Univariate analysis was performed and subsequently logistic regression was used to identify intergroup differences and calculate the odds ratio with a 95% confidence interval (95% CI).
    Results: We included 776 patients [female: 83.1%; median age: 59 (46-71) years]. Groups 1, 2, and 3 comprised 31.1%, 32.6%, and 36.3% of the patients, respectively. Anti-Ro52 antibody alone was more frequently associated with non-rheumatic diseases, older age, and men (p<0.05). Among patients with CTD, the diagnosis of systemic lupus erythematosus is 3 and 2 times more prevalent in groups 2 and 3, respectively, than in group 1 [OR 2.8 (95% CI 1.60, 4.97), p<0.001; OR 2.2 (95% CI 1.28, 3.86), p<0.01]. In group 2, the diagnosis of undifferentiated CTD is more frequent than in the other groups. Group 1 was more frequently associated with inflammatory myositis than group 2 [OR 0.09 (95% CI 0.01, 0.33), p<0.001] or group 3 [OR 0.08 (95% CI 0.01, 0.29), p<0.001]. Group 1 was also more frequently associated with arthritis (p<0.01), interstitial lung disease (p<0.01), and myositis (p<0.01).
    Conclusions: Anti-Ro52+ antibody alone is frequently found in patients with non-rheumatic diseases. In addition, anti-Ro52+ antibody is also prevalent in patients with CTD and associated with clinical phenotypes that are different from anti-Ro60+ antibody.
    Language English
    Publishing date 2024-03-26
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 605886-3
    ISSN 1593-098X ; 0392-856X
    ISSN (online) 1593-098X
    ISSN 0392-856X
    DOI 10.55563/clinexprheumatol/puxml7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top